Bcl-2, Bcl-6, and the International Prognostic Index are prognostic indicators in patients with diffuse large B-cell lymphoma treated with rituximab-containing chemotherapy. (Q53127244)

From Wikidata

Jump to navigation Jump to search

scientific article published on 14 August 2012

Language	Label	Description	Also known as
English	Bcl-2, Bcl-6, and the International Prognostic Index are prognostic indicators in patients with diffuse large B-cell lymphoma treated with rituximab-containing chemotherapy.	scientific article published on 14 August 2012

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/22783941

Bcl-2, Bcl-6, and the International Prognostic Index are prognostic indicators in patients with diffuse large B-cell lymphoma treated with rituximab-containing chemotherapy. (English)

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/22783941

B-cell lymphoma

1 reference

based on heuristic

inferred from title

diffuse large B-cell lymphoma

1 reference

based on heuristic

inferred from title

Yukio Kobayashi

9

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/22783941

10

object named as

Kensei Tobinai

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/22783941

11

object named as

Hitoshi Tsuda

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/22783941

author name string

Akiko Miyagi Maeshima

1

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/22783941

Hirokazu Taniguchi

2

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/22783941

Suguru Fukuhara

3

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/22783941

Noriyuki Morikawa

4

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/22783941

Wataru Munakata

5

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/22783941

Dai Maruyama

6

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/22783941

Sung-Won Kim

7

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/22783941

Takashi Watanabe

8

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/22783941

publication date

14 August 2012

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/22783941

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/22783941

103

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/22783941

10

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/22783941

1898-1904

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/22783941

New approach to classifying non-Hodgkin's lymphomas: clinical features of the major histologic subtypes. Non-Hodgkin's Lymphoma Classification Project

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2012.02382.X

21 January 2018

BCL-6 expression in reactive lymphoid tissue and in B-cell non-Hodgkin's lymphomas

1 reference

https://pubmed.ncbi.nlm.nih.gov/22783941

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

T-cell/histiocyte-rich large B-cell lymphoma: a distinct clinicopathologic entity.

1 reference

https://pubmed.ncbi.nlm.nih.gov/22783941

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical impact of the differentiation profile assessed by immunophenotyping in patients with diffuse large B-cell lymphoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/22783941

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Bcl-6 and Bcl-2 protein expression in diffuse large B-cell lymphoma and follicular lymphoma: correlation with 3q27 and 18q21 chromosomal abnormalities

1 reference

https://pubmed.ncbi.nlm.nih.gov/22783941

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Bcl-6 protein expression in normal and neoplastic lymphoid tissues

1 reference

https://pubmed.ncbi.nlm.nih.gov/22783941

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognostic significance of bcl-2 protein expression in aggressive non-Hodgkin's lymphoma. Groupe d'Etude des Lymphomes de l'Adulte (GELA)

1 reference

https://pubmed.ncbi.nlm.nih.gov/22783941

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Expression of a single gene, BCL-6, strongly predicts survival in patients with diffuse large B-cell lymphoma.

1 reference

https://pubmed.ncbi.nlm.nih.gov/22783941

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

CD5-positive diffuse large B-cell lymphoma: a retrospective study in 337 patients treated by chemotherapy with or without rituximab

1 reference

https://pubmed.ncbi.nlm.nih.gov/22783941

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognostic significance of the Ki-67-associated proliferative antigen in aggressive non-Hodgkin's lymphomas: a prospective Southwest Oncology Group trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/22783941

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

De novo CD5+ diffuse large B-cell lymphoma: a clinicopathologic study of 109 patients.

1 reference

https://pubmed.ncbi.nlm.nih.gov/22783941

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray

1 reference

https://pubmed.ncbi.nlm.nih.gov/22783941

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Subclassification of diffuse large B-cell lymphomas according to the Kiel classification: distinction of centroblastic and immunoblastic lymphomas is a significant prognostic risk factor.

1 reference

https://pubmed.ncbi.nlm.nih.gov/22783941

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling

1 reference

https://pubmed.ncbi.nlm.nih.gov/22783941

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/22783941

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Brentuximab vedotin (SGN-35) for relapsed CD30-positive lymphomas

1 reference

https://pubmed.ncbi.nlm.nih.gov/22783941

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Rituximab plus CHOP (R-CHOP) overcomes bcl-2--associated resistance to chemotherapy in elderly patients with diffuse large B-cell lymphoma (DLBCL).

1 reference

https://pubmed.ncbi.nlm.nih.gov/22783941

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Evaluation of immunophenotype in diffuse large B-cell lymphoma and its impact on prognosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/22783941

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The revised International Prognostic Index (R-IPI) is a better predictor of outcome than the standard IPI for patients with diffuse large B-cell lymphoma treated with R-CHOP

1 reference

https://pubmed.ncbi.nlm.nih.gov/22783941

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A biologic definition of Burkitt's lymphoma from transcriptional and genomic profiling.

1 reference

https://pubmed.ncbi.nlm.nih.gov/22783941

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognostic significance of Bcl-2 protein expression and Bcl-2 gene rearrangement in diffuse aggressive non-Hodgkin's lymphoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/22783941

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognostic impact of immunohistochemically defined germinal center phenotype in diffuse large B-cell lymphoma patients treated with immunochemotherapy.

1 reference

https://pubmed.ncbi.nlm.nih.gov/22783941

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intensified chemotherapy with ACVBP plus rituximab versus standard CHOP plus rituximab for the treatment of diffuse large B-cell lymphoma (LNH03-2B): an open-label randomised phase 3 trial.

1 reference

https://pubmed.ncbi.nlm.nih.gov/22783941

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Modified cyclophosphamide, vincristine, doxorubicin, and methotrexate (CODOX-M)/ifosfamide, etoposide, and cytarabine (IVAC) therapy with or without rituximab in Japanese adult patients with Burkitt lymphoma (BL) and B cell lymphoma, unclassifiable,

1 reference

https://pubmed.ncbi.nlm.nih.gov/22783941

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Altered subcellular localization of c-Myc protein identifies aggressive B-cell lymphomas harboring a c-MYC translocation

1 reference

https://pubmed.ncbi.nlm.nih.gov/22783941

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Rearrangement of the bcl-6 gene as a prognostic marker in diffuse large-cell lymphoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/22783941

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interferon regulatory factors: the next generation

1 reference

https://pubmed.ncbi.nlm.nih.gov/22783941

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Chromosomal translocations cause deregulated BCL6 expression by promoter substitution in B cell lymphoma.

1 reference

https://pubmed.ncbi.nlm.nih.gov/22783941

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The impact of Epstein-Barr virus status on clinical outcome in diffuse large B-cell lymphoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/22783941

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Rituximab therapy in malignant lymphoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/22783941

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Estimating the impact of rituximab on bcl-2-associated resistance to CHOP in elderly patients with diffuse large B-cell lymphoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/22783941

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognostic significance of Bcl-6 protein expression in DLBCL treated with CHOP or R-CHOP: a prospective correlative study

1 reference

https://pubmed.ncbi.nlm.nih.gov/22783941

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Deregulated Bcl-2 gene expression selectively prolongs survival of growth factor-deprived hemopoietic cell lines.

1 reference

https://pubmed.ncbi.nlm.nih.gov/22783941

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Involvement of BCL6 in chromosomal aberrations affecting band 3q27 in B-cell non-Hodgkin lymphoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/22783941

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Large cleaved and immunoblastic lymphoma may represent two distinct clinicopathologic entities within the group of diffuse large B-cell lymphomas.

1 reference

https://pubmed.ncbi.nlm.nih.gov/22783941

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1111/J.1349-7006.2012.02382.X

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/22783941

PMC publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/22783941

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53127244&oldid=2084417889"